Skip to main content
Equibles

Legal & General Group Plc

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 764068 London, X0
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,564
+$16,525 QoQ
Shares Held
17,988
+15.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 130 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. LCTX ranks #234 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in LCTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,564 17,988
2025-03-31 $7,039 15,644
2024-12-31 $7,822 15,644
2024-09-30 $14,236 15,644
2024-06-30 $15,644 15,644
2024-03-31 $23,153 15,644
2023-12-31 $17,051 15,644
2023-09-30 $18,459 15,644
2023-06-30 $22,058 15,644
2022-03-31 $14,897 9,674
2021-12-31 $23,701 9,674
2021-09-30 $24,378 9,674
2021-06-30 $27,570 9,674
2020-03-31 $11,413 13,751